Grant-Funded Research

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002484: Individual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy

Nadine Henderson;George Bray;Chris Skedgel

002482: 2022 OHE Annual Report to the Charity Commission

Office of Health Economics

002472: 2021 OHE Annual Report to the Charity Commission

Mireia Jofre-Bonet

002323: Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?

Patricia Cubi-Molla;David Mott;Nadine Henderson;Martina Garau;Bernarda Zamora;Mendel Grobler

002308: Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

Chris Sampson;David Parkin;Nancy Devlin

002298: Cornerstones of “Fair” Drug Coverage: Appropriate Cost - Sharing and Utilization Management Policies for Pharmaceuticals

Steven D Pearson;Maria Lowe;Celia S. Segal;Chris Henshall;Adrian Towse

002187: The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

Niklas Wallin-Bernhardsson;Peter Lindgren;Mikel Berdud;Bernarda Zamora;Adrian Towse

002184: Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Koonal Shah;Juan Manuel Ramos-Goñi;Nancy Devlin;Oliver Rivero-Arias

002154: The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment

Simon Brassel;Olga Rozanova;Adrian Towse

002150: The Future of Global Health Procurement: Issues around Pricing Transparency

Mikel Berdud;Adrian Towse;Kalipso Chalkidou;Emma Dean;Jimena Ferraro;Lou Garrison;Cassandra Nemzoff

002142: Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

Karla Hernandez-Villafuerte;Yan Feng;David Parkin;Nancy Devlin;Bernarda Zamora;Adrian Towse

002094: Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

Nancy Devlin;Paula Lorgelly;Mike Herdman

002044: Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research

Bernarda Zamora;Adrian Towse;Karla Hernandez-Villafuerte

002040: R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

Mikel Berdud;Martina Garau;Margherita Neri;Phill O’Neill;Chris Sampson;Adrian Towse

002036: Establishing a Reasonable Price for an Orphan Drug

Michael F. Drummond;Mikel Berdud;Adrian Towse

001984: New Methods for Analysing the Distribution of EQ-5D Observations

David Parkin;Yan Feng;Andrew Bateman;Mike Herdman;Nancy Devlin;Bernarda Zamora

001871: Why Do Immigrants Report Lower Life Satisfaction?

Firat Yaman;Patricia Cubi-Molla

001798: What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Nancy Devlin;Koonal Shah;Ken Buckingham

001777: An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Aurea Duran;Nancy Devlin;Phill O’Neill;Amanda Cole

001764: Uncertainty and Risk in HTA Decision Making

Paul Barnsley;Adrian Towse;Patricia Cubi-Molla

001756: The Distribution of the EQ-5D-5L Index in Patient Populations

Bernarda Zamora;Yan Feng;Nancy Devlin;Andrew Bateman;David Parkin

001679: New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data

Yan Feng;Nancy Devlin;Koonal Shah;Brendan Mulhern;Ben van Hout

001678: Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England

Nancy Devlin;Koonal Shah;Yan Feng;Berndan Mulhern;Ben Van Hout

001669: Model of Behaviour within Fuzzy Budget Constraints

Office of Health Economics

001632: Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations

Michele Pistollato

000517: Opportunity Costs of Implementing NICE Decisions in NHS Wales

Sarah Karlsberg-Schaffer;Jon Sussex;Dyfrig Hughs;Nancy Devlin

000175: The Effect of an Increase in the Rate of Payment on General Practitioner's Intrinsic and Extrinsic Motivation

Yan Feng;Shelley Farrar;Matt Sutton;Ada May

000172: Valuing Health at the End of Life: An Exploratory Preference Elicitation Study

Koonal Shah;Aki Tsuchiya;Allan Wailoo

000126: Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity

Koonal Shah;Nancy Devlin

000037: Exploring the link between health and wealth in decision making

Koonal Shah;Priya Sharma;Martina Garau;Adrian Towse